Novavax Inc. (NVAX)
NASDAQ · Healthcare
Novavax Inc. Shareholder Equity 2010–2025
Novavax Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Novavax Inc. shareholder equity as of December 31, 2025: -127.8M, a 79.52% decrease year-over-year.
- Novavax Inc. shareholder equity for 2025 were -127.8M, a 79.52% decrease from 2024.
- Novavax Inc. shareholder equity for 2024 were -623.8M, a 12.98% decrease from 2023.
- Novavax Inc. shareholder equity for 2023 were -716.9M, a 13.07% increase from 2022.
- Novavax Inc. shareholder equity for 2022 were -634.1M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Novavax Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-128 |
| 2024 | $-624 |
| 2023 | $-717 |
| 2022 | $-634 |
| 2021 | $-352 |
| 2020 | $627 |
| 2019 | $-186 |
| 2018 | $-168 |
| 2017 | $-102 |
| 2016 | $-6 |
| 2015 | $293 |
| 2014 | $230 |
| 2013 | $203 |
| 2012 | $80 |
| 2011 | $54 |
Novavax Inc. Shareholder Equity — FAQ
Novavax Inc. (NVAX) shareholder equity over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NVAX's shareholder equity history?
The chart and table above show Novavax Inc.'s shareholder equity by year and by quarter, including the growth rate.